VIR · Categories · Form 4
VIR - SEC Form 4 insider transactions
Vir Biotechnology Inc. (VIR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for VIR
- President and CEO De Backer Marianne disposed of 233,532 shares and acquired 233,532 shares, decreasing direct ownership by 25% to 714,613 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SEC Form 4 filed by De Backer Marianne4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SEC Form 4 filed by Sato Vicki L4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SEC Form 4 filed by Sabatini Brent4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SEC Form 4 filed by O'Byrne Jason4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $209,181 worth of shares (22,000 units at $9.51), decreasing direct ownership by 2% to 1,122,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L exercised 42,377 shares at a strike of $1.49 and sold $413,366 worth of shares (42,377 units at $9.75) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SVP, Chief Accounting Officer Sabatini Brent sold $13,632 worth of Common Stock (1,430 units at $9.53), decreasing direct ownership by 2% to 69,613 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP & Chief Financial Officer O'Byrne Jason sold $15,576 worth of Common Stock (1,634 units at $9.53), decreasing direct ownership by 0.99% to 162,615 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and Chief Medical Officer Eisner Mark sold $33,955 worth of shares (3,505 units at $9.69), decreasing direct ownership by 2% to 154,024 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP, General Counsel, Corp Sec De Verneuil Vanina sold $164,247 worth of Common Stock (16,817 units at $9.77), decreasing direct ownership by 13% to 112,982 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Chief Executive Officer De Backer Marianne sold $140,720 worth of shares (14,762 units at $9.53), decreasing direct ownership by 1% to 1,020,704 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SVP, Chief Accounting Officer Sabatini Brent was granted 25,000 units of Common Stock and sold $13,631 worth of Common Stock (1,829 units at $7.45), increasing direct ownership by 48% to 71,043 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP & Chief Financial Officer O'Byrne Jason was granted 55,000 units of Common Stock and sold $15,569 worth of Common Stock (2,089 units at $7.45), increasing direct ownership by 48% to 164,249 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and Chief Medical Officer Eisner Mark was granted 55,000 shares and sold $15,569 worth of shares (2,089 units at $7.45), increasing direct ownership by 51% to 157,529 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP, General Counsel, Corp Sec De Verneuil Vanina was granted 55,000 units of Common Stock and sold $33,128 worth of Common Stock (4,445 units at $7.45), increasing direct ownership by 64% to 129,799 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Chief Executive Officer De Backer Marianne was granted 285,000 shares and sold $141,894 worth of shares (19,039 units at $7.45), increasing direct ownership by 35% to 1,035,466 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SVP, Chief Accounting Officer Sabatini Brent sold $11,919 worth of Common Stock (1,530 units at $7.79), decreasing direct ownership by 3% to 47,872 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $169,671 worth of shares (22,000 units at $7.71), decreasing direct ownership by 2% to 1,144,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $130,383 worth of shares (22,000 units at $5.93), decreasing direct ownership by 2% to 1,166,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $1,147,786 worth of shares (191,854 units at $5.98) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $132,070 worth of shares (22,000 units at $6.00), decreasing direct ownership by 2% to 1,188,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $1,213,667 worth of shares (189,431 units at $6.41) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $2,906,278 worth of shares (463,774 units at $6.27) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP & Chief Financial Officer O'Byrne Jason sold $37,782 worth of Common Stock (6,799 units at $5.56), decreasing direct ownership by 6% to 110,701 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP, General Counsel, Corp Sec De Verneuil Vanina sold $12,307 worth of Common Stock (2,385 units at $5.16), decreasing direct ownership by 3% to 78,210 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and General Counsel De Verneuil Vanina sold $8,003 worth of Common Stock (1,365 units at $5.86), decreasing direct ownership by 2% to 80,595 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $124,047 worth of shares (22,000 units at $5.64), decreasing direct ownership by 2% to 1,210,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $159,655 worth of shares (24,553 units at $6.50) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $679,870 worth of shares (113,099 units at $6.01) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $1,812,378 worth of shares (298,649 units at $6.07) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $2,058,247 worth of shares (330,210 units at $6.23) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $179,563 worth of shares (29,515 units at $6.08) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $1,543,899 worth of shares (251,360 units at $6.14) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $3,223,939 worth of shares (538,375 units at $5.99) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Large owner Svf Endurance (Cayman) Ltd sold $2,922,426 worth of shares (524,297 units at $5.57) (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $128,396 worth of shares (22,000 units at $5.84), decreasing direct ownership by 2% to 1,232,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $109,811 worth of shares (22,000 units at $4.99), decreasing direct ownership by 2% to 1,254,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $109,699 worth of shares (22,000 units at $4.99), decreasing direct ownership by 2% to 1,276,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and Chief Medical Officer Eisner Mark sold $56,791 worth of shares (10,382 units at $5.47), decreasing direct ownership by 9% to 104,618 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L sold $112,207 worth of shares (22,000 units at $5.10), decreasing direct ownership by 2% to 1,298,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director More Robert J disposed of 14,027 shares and acquired 14,027 shares, decreasing direct ownership by 26% to 40,656 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Bischofberger Norbert W disposed of 10,667 shares and acquired 10,667 units of Common Stock, decreasing direct ownership by 44% to 13,333 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sigal Charles Elliott was granted 8,000 shares, increasing direct ownership by 34% to 31,806 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Sato Vicki L was granted 8,000 shares, increasing direct ownership by 0.61% to 1,320,391 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Ramasastry Saira was granted 8,000 shares, increasing direct ownership by 55% to 22,619 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Napolitano Janet sold $16,149 worth of shares (3,200 units at $5.05) and was granted 8,000 shares, increasing direct ownership by 41% to 16,416 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director More Robert J was granted 8,000 shares, increasing direct ownership by 17% to 54,683 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Hatfield Jeffrey S. was granted 8,000 shares, increasing direct ownership by 34% to 31,806 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Farid Ramy was granted 8,000 shares, increasing direct ownership by 50% to 24,000 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Bischofberger Norbert W was granted 8,000 shares, increasing direct ownership by 50% to 24,000 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Chief Executive Officer De Backer Marianne sold $474,239 worth of shares (79,712 units at $5.95), decreasing direct ownership by 9% to 769,505 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and General Counsel De Verneuil Vanina sold $67,402 worth of Common Stock (7,373 units at $9.14), decreasing direct ownership by 8% to 79,460 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Director Scangos George A sold $95,063 worth of shares (10,056 units at $9.45), decreasing direct ownership by 1% to 698,239 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP & Chief Technology Officer Hanly Ann M. sold $133,936 worth of shares (14,168 units at $9.45), decreasing direct ownership by 11% to 117,901 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP & Chief Financial Officer O'Byrne Jason was granted 40,000 units of Common Stock, increasing direct ownership by 53% to 115,000 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and Chief Medical Officer Eisner Mark was granted 40,000 shares, increasing direct ownership by 53% to 115,000 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- SVP, Chief Accounting Officer Sabatini Brent was granted 20,000 units of Common Stock and sold $14,766 worth of Common Stock (1,562 units at $9.45), increasing direct ownership by 65% to 46,627 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- Chief Executive Officer De Backer Marianne was granted 240,000 shares and sold $152,408 worth of shares (16,122 units at $9.45), increasing direct ownership by 36% to 849,217 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)
- EVP and General Counsel De Verneuil Vanina was granted 35,000 units of Common Stock and sold $48,590 worth of Common Stock (5,140 units at $9.45), increasing direct ownership by 52% to 86,833 units (SEC Form 4)4 - Vir Biotechnology, Inc. (0001706431) (Issuer)